Below is the latest Dana email newsletter. You can sign up to receive this (and other Dana email alerts and/or print publications) by going here.
by Lee Alan Dugatkin
Many animal species besides humans show evidence of individuality. Knowing how a risk-taker differs from its stay-at-home counterpart could not only help humans live more easily with our fellow creatures, says Lee Dugatkin of the University of Louisville, but also tell us a few things about ourselves and how we got this way. From Cerebrum, our online magazine of ideas.
“The results are consistent with the idea that early experience matters relatively more than later,” says one researcher.
Short periods of abstinence from drinking, smoking, or eating junk food may increase the risk of full-blown dependency.
Parkinson’s disease (PD) is the second most common neurodegenerative disease after Alzheimer’s, affecting approximately 5 million persons worldwide. With the population aging, it is anticipated that the number of patients with PD will increase dramatically in the coming decades. One of our series of Reports on Progress.
In a Dana grantee Q&A, John Chen discusses how a new MRI technique reveals a potential biomarker of inflammation and a target for less toxic Multiple Sclerosis treatments.
See also: our recent Cerebrum story, “Cognitive Impairment in Multiple Sclerosis.”
What does it mean for society that use of smart drugs is increasing among cognitively healthy people?
Last call for entries! The Dana Foundation is asking high school students to design original brain-related experiments. The winners receive cash prizes. The last day to submit entries is next Thursday, January 17.